Eric Bjerkholt
2023
In 2023, Eric Bjerkholt earned a total compensation of $4.3M as Chief Financial Officer at Mirum Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $95,246 |
|---|---|
| Option Awards | $2,417,470 |
| Salary | $151,562 |
| Stock Awards | $1,673,650 |
| Total | $4,337,928 |
Bjerkholt received $2.4M in option awards, accounting for 56% of the total pay in 2023.
Bjerkholt also received $95.2K in non-equity incentive plan, $151.6K in salary and $1.7M in stock awards.
Rankings
In 2023, Eric Bjerkholt's compensation ranked 170th out of 2,983 executives tracked by ExecPay. In other words, Bjerkholt earned more than 94.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 170 out of 2,983 | 94th |
Division Manufacturing | 87 out of 1,637 | 95th |
Major group Chemicals And Allied Products | 53 out of 906 | 94th |
Industry group Drugs | 52 out of 869 | 94th |
Industry Pharmaceutical Preparations | 35 out of 627 | 94th |
Source: SEC filing on April 23, 2024.
Bjerkholt's colleagues
We found two more compensation records of executives who worked with Eric Bjerkholt at Mirum Pharmaceuticals in 2023.